Cargando…
A Novel PDK1/MEK Dual Inhibitor Induces Cytoprotective Autophagy via the PDK1/Akt Signaling Pathway in Non-Small Cell Lung Cancer
In a preliminary study, we synthesized a series of new PDK1/MEK dual inhibitors. Antitumor activity screening showed that Compound YZT exerts a strong inhibitory action in A549 cells. However, the specific mechanism of YZT against non-small cell lung cancer (NSCLC) is largely unknown. This work conf...
Autores principales: | Liu, Rangru, Chen, Zhuo, Hu, Gaoyun, Yu, Zutao, Li, Qianbin, Liu, Danqi, Li, Ling, Liu, Zhaoqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961937/ https://www.ncbi.nlm.nih.gov/pubmed/37259393 http://dx.doi.org/10.3390/ph16020244 |
Ejemplares similares
-
A novel dual MEK/PDK1 inhibitor 9za retards the cell cycle at G(0)/G(1) phase and induces mitochondrial apoptosis in non-small cell lung cancer cells
por: Liu, Rangru, et al.
Publicado: (2020) -
SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling
por: Bao, Fan, et al.
Publicado: (2023) -
The Landscape of PDK1 in Breast Cancer
por: Wang, Na, et al.
Publicado: (2022) -
Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer
por: Lucero-Acuña, Armando, et al.
Publicado: (2014) -
PKCθ-Mediated PDK1 Phosphorylation Enhances T Cell Activation by Increasing PDK1 Stability
por: Kang, Jung-Ah, et al.
Publicado: (2017)